CAT-8015: A Second-generation Pseudomonas Exotoxin A-Based Immunotherapy Targeting CD22 -Expressing Hematological Malignancies

per Alderson, Ralph F., Kreitman, Robert J., Chen, Tianling, Yeung, Peter, Herbst, Ronald, Fox, Judy A., Pastan, Ira
Publicat 2009

Phase I and Pharmacologic Study of SNS-032, a Potent and Selective Cdk2, 7, and 9 Inhibitor, in Patients With Advanced Chronic Lymphocytic Leukemia and Multiple Myeloma

per Tong, Wei-Gang, Chen, Rong, Plunkett, William, Siegel, David, Sinha, Rajni, Harvey, R. Donald, Badros, Ashraf Z., Popplewell, Leslie, Coutre, Steven, Fox, Judith A., Mahadocon, Kristi, Chen, Tianling, Kegley, Peggy, Hoch, Ute, Wierda, William G.
Publicat a J Clin Oncol (2010)

A phase 1b/2 study of vosaroxin in combination with cytarabine in patients with relapsed or refractory acute myeloid leukemia

per Lancet, Jeffrey E., Roboz, Gail J., Cripe, Larry D., Michelson, Glenn C., Fox, Judith A., Leavitt, Richard D., Chen, Tianling, Hawtin, Rachael, Craig, Adam R., Ravandi, Farhad, Maris, Michael B., Stuart, Robert K., Karp, Judith E.
Publicat a Haematologica (2015)